The Influence of Low Salivary Flow Rates on the Absorption of a Sublingual Fentanyl Citrate Formulation for Breakthrough Cancer Pain-Reference-Cited by-同舟云学术

The Influence of Low Salivary Flow Rates on the Absorption of a Sublingual Fentanyl Citrate Formulation for Breakthrough Cancer Pain

Published:2016-03 Issue:3 Volume:51 Page:538-545
ISSN:0885-3924
Container-title:Journal of Pain and Symptom Management
language:en
Short-container-title:Journal of Pain and Symptom Management

Author:

Davies Andrew,Mundin Gill,Vriens Joanna,Webber Kath,Buchanan Alison,Waghorn Melanie

Funder

Dr. Davies's Research Fund

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,General Nursing

Reference32 articles.

1. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland;Davies;Eur J Pain,2009

2. A survey of Canadian cancer patients' perspectives on the characteristics and treatment of breakthrough pain;Bedard;Support Care Cancer,2013

3. Breakthrough cancer pain: an observational study of 1000 European oncology patients;Davies;J Pain Symptom Manage,2013

4. Oral opioid drugs;Bailey,2006

5. Abstral® Summary of Product Characteristics. 2015. Available at: http://www.medicines.org.uk/emc/medicine/21371/SPC/Abstral+Sublingual+Tablets/. Accessed January 4, 2016.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pharmacist Perspective on Optimizing Pharmacotherapy among Older Adults – A Review;F1000Research;2024-07-05

2. Breakthrough pain and rapid-onset opioids in patients with cancer pain: a narrative review;Journal of Yeungnam Medical Science;2024-01-31

3. The Efficacy and Safety of Acupuncture on Xerostomia in Patients with Sjogren’s Syndrome: A Systematic Review and Network Meta-analysis Protocol;2023-06-06

4. Analyzing Differences in Perception between Oncologists and Patients to Adapt Pharmacological Treatment for Breakthrough Cancer Pain: Observational ADAPTATE Study;Journal of Palliative Medicine;2022-06-01

5. Analgetika;Arzneimitteltherapie in der Palliativmedizin;2022